Esorubicin (deoxyadriamycin; IMI-58; IMI58) is a chemically modified analogue of the anthracycline anticancer antibiotic doxorubicin with less cardiotoxicity. As a doxorubicin analog, it has potential antineoplastic activity by acting as a topoisomerase II inhibitor and a DNA intercalator.

纯度：≥98%

CAS：63521-85-7